Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. [electronic resource]
- The British journal of dermatology Aug 2008
- 387-93 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
1365-2133
10.1111/j.1365-2133.2008.08668.x doi
Adult Aged Aged, 80 and over Aminolevulinic Acid--therapeutic use Carcinoma, Basal Cell--drug therapy Dose-Response Relationship, Drug Female Humans Iron Chelating Agents--adverse effects Male Middle Aged Pain--etiology Photochemotherapy--adverse effects Photosensitizing Agents--therapeutic use Pilot Projects Pyridones--adverse effects Skin Neoplasms--drug therapy Treatment Outcome